Norwegian holding company is driven by youth. Ellingsen Technologies & Ellingsen Partners. Ellingsen Group is a company that aims to create a platform for creators and artists. We believe in art, therefore we want to create a stable income for creators with our two main projects. These two projects are Properfans and Bitful.

CatalystOne Solutions is a rapidly growing SaaS company with over 200 passionate employees who all work towards a common goal: enabling businesses to thrive. We don't consider ourselves merely a software supplier, but as a partner who works closely with our customers to ensure they gain the maximum value from their HR solution. That's why we provide consistent support and deliver results beyond expectations. Our purpose is to enable businesses to thrive.

Cavai AS was founded in December 2017 with the goal of revolutionizing online advertising. User experiences have largely been neglected on the web, and Cavai saw early on that chatbot technology, which has initially been used in customer service, could be a wonderfully good advertising product. Usually, chatbot technology is used as customer service on its own website, while Cavai's platform is built to be able to use chatbot technology on millions of websites for contextual advertising. The team today consists of 15 people, and the product has been launched in Norway, Finland, Sweden and the UK with 50 paying customers. Customers are very pleased and report that Cavai's technology is having a very good effect on completed advertising campaigns. Cavai will have its first month of positive operating results in October and looks to have sales of around 3 million in 2019. Next year will be a big growth year, where we have budgeted with a turnover of NOK 41 million. This growth has also been discussed by Finansavisen, where as part of Finansavisen's web-TV series "Vext", Cavai filmed his meeting with advertising legend Sir Marting Sorell in London. For more information, see https://finansavisen.no/vext/tech/2019/10/23/7465643/chatbot-company-cavai-2020-blir-the-store-growst>  To finance further growth, we are now running a seed funding round of NOK 9.5 - 15 million. The company is priced at NOK 60 million pre-money. For more information see the investor summary, investor presentation and subscription form attached.

Cloud-native microenvironment control for developing & scaling complex cell models. We offer solutions for vertically integrating 2D and 3D assays into your workflow, all the while you maintain real-time control over relevant readouts and variables. Find out more on www.vitroscope.no or reach out under contact@vitroscope.no

Ava was acquired by Motorola Solutions in 2022 and is now part of its portfolio. Ava is a global technology company with offices in the UK, Norway, and the USA. We exist because we believe that we can create a better, smarter way to deliver security. We help organizations see, understand, and act on their surroundings to protect their people, business, and reputation in real time.

Quantfolio is a Bergen based Fintech company delivering “AI-in-a-box” components for banks & wealth managers with a digitial presence. Through open API´s and machine learning algorithms we empower banks and WM’s with our AI investment components to provide their customers with anything from automated low cost savings portfolios to sophisticated investment strategies normally reserved for HNW individuals. Our team consist of passionate and highly skilled individuals, ranging from serial entrepreneurs, traders, quants and developers with PhDs within machine learning. Quantfolio is partly owned by Skandiabanken, Norway’s largest challenger bank, also our first customer launching Q3/Q4 2017.Our HQ is based in Bergen with a quant team based in San Diego.

Zelo redefines how companies communicate internally. Streamline your internal communications by optimizing your reach. Compose, send, and track company updates across email, SMS, Teams & Slack in minutes. Use the Preferred Communication Channels Create great messages and distribute them across the channels your audience is most receptive to including email, SMS, Slack, MS Teams, and more.

We have developed a system for calculating and supplying Solcelle, and wind power for Scandinavia. In addition to this, we have obtained a license as a power supplier, so we can offer our customers both purchases and sales of green power. Why solar cells? Sun provides energy. As an energy source, the sun is unsurpassed. Every year, the earth receives 15,000 times more energy from the sun than the earth's population uses. Even in Norway, the sun provides 1,500 times more energy than what we use. Depending on where on the globe you are, the sun provides an amount of energy from 700 to over 2,200 kWh/m2 per year.

Kikora is one of Norway's leading digital edtech companies. We provide an e-learning platform for mathematics. Our unique maths engine and technology platform contributes to better learning among several hundred thousand Norwegian students. We consider ourselves one of the best places in edtech to work. Over half of Norway's students use Kikora, and we are growing.

Oncoinvent AS is a privately held Norwegian company established in 2010. The company is committed to developing new innovative products to provide better treatment options to cancer patients. The innovations being developed by Oncoinvent AS are a result of the extensive experience with the development of radionuclide-based cancer treatments of two of the founders, Dr. Roy H. Larsen and Professor of clinical oncology Øyvind S. Bruland. Larsen and Bruland are the inventors of the first FDA and EMA-approved alpha-emitting pharmaceutical product Xofigo® (Bayer AG), as well as of the beta-emitting radio-immunotherapeutic product candidate Betalutin® (Nordic Nanovector ASA). Oncoinvent's lead product candidate, Radspherin®, is a novel alpha-emitting radioactive microsphere designed for the treatment of metastatic cancers in body cavities. Radspherin® has been shown to cause a significant reduction in tumor cell growth. It is anticipated that the product can potentially treat several forms of metastatic cancer. The first clinical indication for Radspherin® will be the treatment of peritoneal carcinomatosis. Clinical development will be conducted in collaboration with European and American clinical research centers.

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.

Building a "børs"  for the worlds non for profit organisation in Oslo. Oslo Philanthropic Exchange is a non-profit foundation. Our mission is to bring the best practice from the global capital markets to raise philanthropic funding more efficiently. Our goal is to contribute to higher impact of philanthropic capital. The OPX Solution addresses the inefficient funding of the non-profit sector and the lack of standardised, transparent and comparable data. By applying best practice from the capital markets for listing of non-profit organisations and reporting requirements as well as leveraging existing infrastructures, we standardise and digitalise to increase efficiency, transparency, accountability and accessibility. The OPX Solution represent the complete value chain of finding, filtering, funding and following the world’s non-profit organisations.

BAD NORWEGIAN is a natural skincare brand from Norway, founded by a former NATO soldier, to offer men simple products and routines. We combine the values associated with Norway: integrity, honesty, and quality- with a rogue, confident undertone. Our skincare, beard and shave products are all cruelty-free and vegan, with an instant effect. BAD NORWEGIAN is a direct-to-consumer company with a strong foothold in the travel retail market in Norway. Selling at Heinemann, BEAST, Marionnaud and Cult Beauty.

Refyne så dagens lys i efteråret 2020 og er siden blevet et af de mest respekterede og seniortunge bureauer i Danmark med mere end 20+ ansatte Vi arbejder med skræddersyede og databaserede strategier inde for SEO, Paid Search & Social, Tracking, Webanalyse og Konverteringsoptimering. Vores målsætning er at være det mest kompetente bureau, ikke det største bureau. Det er vi gennem vores nytænkende løsninger og ved at levere forretningsmæssige resultater for vores kunder. Vi arbejder både med scale-ups og markedsledende virksomheder.

Golfer Sweden is a tech company within the golf industry. Through our integration platform we connect Golf clubs, golf players and business into a digital eco-system. Our app is currently Sweden's most used golf app with over 300,000 users and 6.5 million bookings. For operators of golf courses: we offer a solution which allows owners to run a smart, efficient and profitable business, closely connected to all relevant costumers For Golf players: we offer golf players a way to easily manage their golf experience before, during, and after their round. For commercial stakeholders in the golf ECO-system: we provide data and innovative tools for commercial stakeholders to reach and connect with their target audience.